Presentation and progression of MPO-ANCA interstitial lung disease

Presentation and progression of MPO-ANCA interstitial lung disease

The association between MPO-ANCA-associated vasculitis (AAV) and interstitial lung disease (ILD) has been well established. Pulmonary fibrosis may coexist with, follow, or even precede the diagnosis of AAV, and its presence adversely affects the prognosis. The optimal approach to investigating ANCA...

Full description

Bibliographic Details
Main Authors:	Lorenzo Salvati, Boaz Palterer, Elena Lazzeri, Emanuele Vivarelli, Marina Amendola, Marco Allinovi, Leonardo Caroti, Alessio Mazzoni, Laura Lasagni, Giacomo Emmi, Edoardo Cavigli, Marco Del Carria, Linda Di Pietro, Mariangela Scavone, Daniele Cammelli, Federico Lavorini, Sara Tomassetti, Elisabetta Rosi, Paola Parronchi
Format:	Article
Language:	English
Published:	Elsevier 2024-06-01
Series:	Journal of Translational Autoimmunity
Subjects:	ANCA-Associated vasculitis Interstitial lung disease Glomerulonephritis MPO UIP MPO-ANCA
Online Access:	http://www.sciencedirect.com/science/article/pii/S2589909024000054

Similar Items

Neutrophil Extracellular Traps: A Potential Therapeutic Target in MPO-ANCA Associated Vasculitis?
by: Kim M. O'Sullivan, et al.
Published: (2021-03-01)

Rituximab in relapsing and de novo MPO ANCA-associated vasculitis with severe renal involvement: a case series
by: L. Caroti, et al.
Published: (2019-05-01)

Newly diagnosed ANCA-associated vasculitis after COVID-19 infection: a case report
by: Kazuhiro Kitamoto, et al.
Published: (2023-08-01)

Systematic Histological Scoring Reveals More Prominent Interstitial Inflammation in Myeloperoxidase-ANCA Compared to Proteinase 3-ANCA Glomerulonephritis
by: Samy Hakroush, et al.
Published: (2021-03-01)

A Transient Increase in the Serum ANCAs in Patients with SARS-CoV-2 Infection: A Signal of Subclinical Vasculitis or an Epiphenomenon with No Clinical Manifestations? A Pilot Study
by: Monica Gelzo, et al.
Published: (2021-08-01)

Enho Mutations Causing Low Adropin: A Possible Pathomechanism of MPO-ANCA Associated Lung Injury
by: Feng Gao, et al.
Published: (2016-07-01)

Implication of platelets and complement C3 as link between innate immunity and tubulointerstitial injury in renal vasculitis with MPO-ANCA seropositivity
by: Eva Baier, et al.
Published: (2022-11-01)

Case report: A pediatric case of MPO-ANCA-associated granulomatosis with polyangiitis superimposed on post-streptococcal acute glomerulonephritis
by: Qianhuining Kuang, et al.
Published: (2023-07-01)

Microscopic polyangiitis associated with thymic tumor: a case report and review of the literature
by: Yasunori Miyamoto, et al.
Published: (2019-04-01)

MPO-ANCA Associated Vasculitis Following COVID-19 Vaccination – A Case Report
by: Mahmoud Khalifa, et al.
Published: (2021-05-01)

C-Reactive Protein Levels Are Associated with Complement C4 Deposits and Interstitial Arteritis in ANCA-Associated Renal Vasculitis
by: Peter Korsten, et al.
Published: (2023-02-01)

The potential pathogenic roles of S100A8/A9 and S100A12 in patients with MPO-ANCA-positive vasculitis
by: Xue Bai, et al.
Published: (2022-09-01)

The incidence of anti-neutrophil cytoplasmic antibody (ANCA) with IFA-method in patients with Rheumatoid arthritis (RA) and systemic Lupus erythematous (SLE)
by: Saeedi M (MSc), et al.
Published: (1999-03-01)

Clinical characteristics and primary outcomes of patients with ANCA-associated vasculitis and central diabetes insipidus
by: Xin Chen, et al.
Published: (2023-05-01)

Bruton’s tyrosine kinase is a possible therapeutic target in microscopic polyangiitis
by: Issei Nakade, et al.
Published: (2023-11-01)

Association of HLA-class II alleles with risk of relapse in myeloperoxidase-antineutrophil cytoplasmic antibody positive vasculitis in the Japanese population
by: Aya Kawasaki, et al.
Published: (2023-03-01)

Rituximab induction therapy for de novo ANCA associated vasculitis in pregnancy: a case report
by: Claire Harris, et al.
Published: (2018-06-01)

Improvement of indirect immunofluorescence technique to detect antineutrophil cytoplasmic antibodies and its impact on test positivity rate
by: E.B. Zarur, et al.
Published: (2023-07-01)

Low Density Granulocytes in ANCA Vasculitis Are Heterogenous and Hypo-Responsive to Anti-Myeloperoxidase Antibodies
by: Aisling Ui Mhaonaigh, et al.
Published: (2019-11-01)

Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and fibromyalgia: PR3-versus MPO-ANCA-associated vasculitis, an exploratory cross-sectional studyResearch in context
by: Charmaine van Eeden, et al.
Published: (2023-04-01)

Efficacy of a recombinant single-chain fragment variable region, VasSF, as a new drug for vasculitis
by: Kameoka Y, et al.
Published: (2019-02-01)

Comparative Histological Subtyping of Immune Cell Infiltrates in MPO-ANCA and PR3-ANCA Glomerulonephritis
by: Samy Hakroush, et al.
Published: (2021-10-01)

Clarithromycin-induced eosinophilic granulomatosis with polyangiitis: A case report
by: Yoshio Nakano, et al.
Published: (2023-01-01)

Abundant neutrophil extracellular traps in thrombus of patient with microscopic polyangiitis
by: Daigo eNakazawa, et al.
Published: (2012-11-01)

Clinical and Prognostic Significance of p-ANCA Positivity in Idiopathic Pulmonary Fibrosis: A Retrospective Observational Study
by: Alessandro Libra, et al.
Published: (2023-05-01)

STRATEGI PENGEMBANGAN INSTALASI FARMASI BERBASIS EVALUASI AKREDITASI MANAJEMEN PENGGUNAAN OBAT (MPO) RUMAH SAKIT
by: Noval Noval, et al.
Published: (2016-09-01)

EGPA Phenotyping: Not Only ANCA, but Also Eosinophils
by: Andrea Matucci, et al.
Published: (2023-03-01)

Presence of anti-Glomerular basement membrane (GBM) antibodies and Myeloperoxidase anti neutrophilic cytoplasmic antibodies (MPO ANCA) in a case of rapidly progressive glomerulonephritis.
by: Gaurang P Mavani, et al.
Published: (2015-08-01)

Establishment of IFA technique for detecting ANCA
by: M.Saeedi (M.Sc), et al.
Published: (2001-09-01)

Diagnostic and treatment challenge of unrecognized subacute bacterial endocarditis associated with ANCA-PR3 positive immunocomplex glomerulonephritis: a case report and literature review
by: D. Bele, et al.
Published: (2020-01-01)

Serum MPO levels and activities are associated with angiographic coronary atherosclerotic plaque progression in type 2 diabetic patients
by: Qiujing Chen, et al.
Published: (2022-11-01)

MPO-ANCA associated vasculitis with mononeuritis multiplex following influenza vaccination
by: Stefanie Eindhoven, et al.
Published: (2017-12-01)

MPO-ANCA-associated necrotizing glomerulonephritis in rheumatoid arthritis; a case report and review of literature
by: Mário Góis, et al.
Published: (2017-04-01)

Complement Inhibition in ANCA-Associated Vasculitis
by: Vladimir Tesar, et al.
Published: (2022-07-01)

Renal thrombotic microangiopathy in an ANCA-associated vasculitis
by: Ana Teresa Domingos, et al.
Published: (2019-10-01)

MPO–ANCA-Positive Granulomatosis with Polyangiitis with Rapidly Progressive Glomerulonephritis and Saddle-Nose Deformity: A Case Report
by: Dimitra Petrou, et al.
Published: (2022-05-01)

Polymorphisms in NQO1 and MPO genes and risk for bladder cancer in Tunisian population
by: Imen Hemissi, et al.
Published: (2021-11-01)

Automated Computational Detection of Disease Activity in ANCA-Associated Glomerulonephritis Using Raman Spectroscopy: A Pilot Study
by: Adam D. Morris, et al.
Published: (2022-04-01)

The Role of Neutrophils in ANCA-Associated Vasculitis: The Pathogenic Role and Diagnostic Utility of Autoantibodies
by: Agata Walulik, et al.
Published: (2023-12-01)

Reversible Sensorineural Hearing Loss due to Pachymeningitis Associated with Elevated Serum MPO-ANCA
by: Eun-Jung Lim, et al.
Published: (2011-09-01)